Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hikma Pharmaceuticals PLC (GB:HIK)
LSE:HIK
RESEARCH TOOLSreports
Holding GB:HIK?
Track your performance easily
Hikma Pharmaceuticals (HIK) Ownership Overview
8.96% Insiders
8.16% Mutual Funds
8.63% Other Institutional Investors
74.25% Public Companies and
Individual Investors
The ownership structure of Hikma Pharmaceuticals (GB:HIK) stock is a mix of institutional, retail and individual investors. Approximately 16.79% of the company’s stock is owned by Institutional Investors, 8.96% is owned by Insiders and 74.25% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 13, 2024 | Bassam Kanaan Chief Strategy Officer | xxxxxxxxxxxxx | £888498 |
| Mar 13, 2024 | Susan Ringdal Vice President | xxxxxxxxxxxxx | £156328 |
| Mar 13, 2024 | Brian Hoffmann Divisional President | xxxxxxxxxxxxx | £175914 |
| Mar 07, 2024 | Julie Hill Divisional Vice President | xxxxxxxxxxxxx | £42212 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,196,450 | Insider | 6.40% | 271,720,053 | |
| 7,025,696 | Institution | 3.17% | 182,351,940 | |
| 5,821,997 | Institution | 2.62% | 151,109,932 | |
| 5,437,941 | Institution | 2.45% | 141,141,759 | |
| 2,244,747 | Institution | 1.01% | 58,262,408 | |
| 2,006,299 | Insider | 0.90% | 38,400,563 | |
| 1,475,404 | Institution | 0.66% | 38,294,111 | |
| 1,355,285 | Institution | 0.61% | 35,176,422 | |
| 1,353,721 | Insider | 0.61% | 25,910,220 | |
| 1,087,647 | Institution | 0.49% | 28,229,878 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,437,941 | Institution | 2.45% | 141,141,759 | |
| 2,244,747 | Institution | 1.01% | 58,262,408 | |
| 1,355,285 | Institution | 0.61% | 35,176,422 | |
| 804,549 | Institution | 0.36% | 20,882,069 | |
| 743,959 | Institution | 0.34% | 19,309,456 | |
| 724,338 | Institution | 0.33% | 18,800,193 | |
| 701,528 | Institution | 0.32% | 18,208,159 | |
| 527,308 | Institution | 0.24% | 13,686,279 | |
| 513,140 | Institution | 0.23% | 13,318,549 | |
| 481,408 | Institution | 0.22% | 12,494,945 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,262,688 | Institution | 1.02% | 55,322,387 | |
| 1,367,233 | Institution | 0.62% | 33,428,647 | |
| 994,026 | Institution | 0.45% | 25,710,215 | |
| 975,975 | Institution | 0.44% | 24,631,911 | |
| 544,100 | Institution | 0.25% | 14,073,000 | |
| 366,434 | Institution | 0.17% | 9,477,717 | |
| 336,173 | Institution | 0.15% | 8,219,381 | |
| 316,544 | Institution | 0.14% | 7,739,455 | |
| 302,560 | Institution | 0.14% | 7,640,293 | |
| 397,064 | Institution | 0.18% | 7,560,099 |
FAQ
Who Owns Hikma Pharmaceuticals PLC (GB:HIK)?
According to the latest TipRanks data, approximately 8.63% of the company's stock is held by institutional investors, 8.96% is held by insiders, and 74.25% is held by retail investors.
What percentage of Hikma Pharmaceuticals PLC (GB:HIK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 8.63% of Hikma Pharmaceuticals PLC (GB:HIK) stock is held by institutional investors.
What percentage of Hikma Pharmaceuticals PLC (GB:HIK) stock is held by retail investors?
According to the latest TipRanks data, approximately 74.25% of Hikma Pharmaceuticals PLC (GB:HIK) stock is held by retail investors.
Who owns the most shares of Hikma Pharmaceuticals PLC (GB:HIK)?
Said Darwazah owns the most shares of Hikma Pharmaceuticals PLC (GB:HIK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.